{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T01:05:58Z","timestamp":1790211958234,"version":"4.1.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmoodanxdisorders.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Mood &amp; Anxiety Disorders"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.xjmad.2026.100195","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T16:11:28Z","timestamp":1784909488000},"page":"100195","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Bipolar disorder in oncology: Considerations for the psychiatrist"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6916-5044","authenticated-orcid":false,"given":"Alyssa C.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6051-1601","authenticated-orcid":false,"given":"Sabin","family":"Karki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Semanti J.","family":"Naiken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0573-4420","authenticated-orcid":false,"given":"Susan K.","family":"Conroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Strakowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xjmad.2026.100195_bib1","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","author":"Association","year":"2013","journal-title":"Diagn Stat Man Ment Disord"},{"issue":"14","key":"10.1016\/j.xjmad.2026.100195_bib2","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1001\/jama.2023.18588","article-title":"Diagnosis and Treatment of Bipolar Disorder: A Review","volume":"330","author":"Nierenberg","year":"2023","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.xjmad.2026.100195_bib3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1399-5618.2012.01011.x","article-title":"Meta-analysis of the association between cognitive abilities and everyday functioning in bipolar disorder","volume":"14","author":"Depp","year":"2012","journal-title":"Bipolar Disord"},{"issue":"-1","key":"10.1016\/j.xjmad.2026.100195_bib4","article-title":"The Risk and The Course of Cancer Among People with Severe Mental Illness","volume":"19","author":"Grassi","year":"2023","journal-title":"Clin Pract Epidemiol Ment Health"},{"issue":"4","key":"10.1016\/j.xjmad.2026.100195_bib5","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/s41591-022-01740-3","article-title":"Cumulative burden of psychiatric disorders and self-harm across 26 adult cancers","volume":"28","author":"Chang","year":"2022","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.xjmad.2026.100195_bib6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/0284186X.2021.1992008","article-title":"Prevalence of mental disorders in patients with cancer compared to matched controls - secondary analysis of two nationally representative surveys","volume":"61","author":"Vehling","year":"2022","journal-title":"Acta Oncol"},{"issue":"5","key":"10.1016\/j.xjmad.2026.100195_bib7","doi-asserted-by":"crossref","first-page":"450","DOI":"10.6004\/jnccn.2023.0026","article-title":"NCCN Guidelines\u00ae Insights: Distress Management, Version 2.2023","volume":"21","author":"Riba","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.xjmad.2026.100195_bib8","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jad.2023.04.030","article-title":"Non-adherence to mood stabilizers and antipsychotics among persons with bipolar disorder \u2013 A nationwide cohort study","volume":"333","author":"Lintunen","year":"2023","journal-title":"J Affect Disord"},{"issue":"6","key":"10.1016\/j.xjmad.2026.100195_bib9","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/pon.6138","article-title":"Barriers in cancer trajectories of patients with pre-existing severe mental disorders-A systematic review","volume":"32","author":"Bentson","year":"2023","journal-title":"Psychooncology"},{"issue":"12","key":"10.1016\/j.xjmad.2026.100195_bib10","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1002\/pon.5805","article-title":"Mortality from cancer in people with severe mental disorders in Emilia Romagna Region, Italy","volume":"30","author":"Grassi","year":"2021","journal-title":"Psychooncology"},{"issue":"3","key":"10.1016\/j.xjmad.2026.100195_bib11","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/pon.6081","article-title":"Impact of pre-existing mental health disorders on the receipt of guideline recommended cancer treatments: A systematic review","volume":"32","author":"Wang","year":"2023","journal-title":"Psychooncology"},{"issue":"7","key":"10.1016\/j.xjmad.2026.100195_bib12","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1634\/theoncologist.2018-0488","article-title":"Bridge: Person-Centered Collaborative Care for Patients with Serious Mental Illness and Cancer","volume":"24","author":"Irwin","year":"2019","journal-title":"Oncologist"},{"key":"10.1016\/j.xjmad.2026.100195_bib13","article-title":"Risk factors associated with suicidal ideation among cancer patients: a systematic review and meta-analysis","volume":"14","author":"Chen","year":"2023","journal-title":"Front Psychol"},{"issue":"2","key":"10.1016\/j.xjmad.2026.100195_bib14","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1017\/S1478951519000610","article-title":"Suicidal ideation in patients with cancer: A systematic review of prevalence, risk factors, intervention and assessment","volume":"18","author":"Kolva","year":"2020","journal-title":"Palliat Support Care"},{"issue":"S1","key":"10.1016\/j.xjmad.2026.100195_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpsy.2017.01.1137","article-title":"Suicide Risk in Cancer Patients \u2013 Are We Prepared?","volume":"41","author":"Alves","year":"2017","journal-title":"Eur Psychiatry"},{"issue":"1-3","key":"10.1016\/j.xjmad.2026.100195_bib16","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jad.2012.04.041","article-title":"Suicidal behavior in bipolar disorder: epidemiology, characteristics and major risk factors","volume":"143","author":"Gonda","year":"2012","journal-title":"J Affect Disord"},{"issue":"1","key":"10.1016\/j.xjmad.2026.100195_bib17","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1176\/appi.neuropsych.21030084","article-title":"Primary CNS Lymphoma and Secondary Causes of Mania: A Case Report and Literature Review","volume":"34","author":"Wang","year":"2022","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"3","key":"10.1016\/j.xjmad.2026.100195_bib18","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/bdi.12387","article-title":"Mania secondary to focal brain lesions: implications for understanding the functional neuroanatomy of bipolar disorder","volume":"18","author":"Satzer","year":"2016","journal-title":"Bipolar Disord"},{"issue":"55","key":"10.1016\/j.xjmad.2026.100195_bib19","doi-asserted-by":"crossref","first-page":"94932","DOI":"10.18632\/oncotarget.19843","article-title":"Association between depression and brain tumor: a systematic review and meta-analysis","volume":"8","author":"Huang","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.xjmad.2026.100195_bib20","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2190\/CM8E-46R5-9AJL-03FN","article-title":"The co-occurrence of mania with medical and other psychiatric disorders","volume":"24","author":"Strakowski","year":"1994","journal-title":"Int J Psychiatry Med"},{"issue":"1","key":"10.1016\/j.xjmad.2026.100195_bib21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41572-025-00650-1","article-title":"Autoimmune encephalitis","volume":"11","author":"de Bruijn","year":"2025","journal-title":"Nat Rev Dis Prim"},{"issue":"21","key":"10.1016\/j.xjmad.2026.100195_bib22","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000042472","article-title":"Approach and overview of autoimmune encephalitis: A review","volume":"104","author":"Yucel","year":"2025","journal-title":"Med (Baltim)"},{"issue":"21","key":"10.1016\/j.xjmad.2026.100195_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16213571","article-title":"Cancer Therapy-Induced Encephalitis","volume":"16","author":"Desbaillets","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.xjmad.2026.100195_bib24","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.xjmad.2026.100195_bib25","article-title":"Diagnostic Challenges and Treatment Approach to Seronegative Autoimmune Encephalitis","volume":"16","author":"Bhasin","year":"2024","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.xjmad.2026.100195_bib26","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S1470-2045(11)70002-X","article-title":"Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies","volume":"12","author":"Mitchell","year":"2011","journal-title":"Lancet Oncol"},{"issue":"Pt B","key":"10.1016\/j.xjmad.2026.100195_bib27","article-title":"Real-world pharmacovigilance analysis of depression associated with antineoplastic agents","volume":"393","author":"Chen","year":"2026","journal-title":"J Affect Disord"},{"key":"10.1016\/j.xjmad.2026.100195_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101967","article-title":"Psychiatric disorders associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database","volume":"59","author":"Zhou","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.xjmad.2026.100195_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1268672","article-title":"Neuropsychiatric adverse drug reactions with oral tyrosine kinase inhibitors in metastatic colorectal cancer: an analysis from the FDA Adverse Event Reporting System","volume":"13","author":"Barbieri","year":"2023","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.xjmad.2026.100195_bib30","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/1097-0142(20000715)89:2<356::AID-CNCR21>3.0.CO;2-Z","article-title":"Adjuvant therapy of melanoma with interferon-alpha-2b is associated with mania and bipolar syndromes","volume":"89","author":"Greenberg","year":"2000","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.xjmad.2026.100195_bib31","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1001\/archpsyc.1993.01820180059006","article-title":"A prospective follow-up of patients with bipolar and primary unipolar affective disorder","volume":"50","author":"Winokur","year":"1993","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.xjmad.2026.100195_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1628765","article-title":"Corticosteroid-induced manic and\/or psychotic symptoms: a systematic review","volume":"16","author":"Gostoli","year":"2025","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.xjmad.2026.100195_bib33","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00213-022-06293-4","article-title":"Antipsychotics and risk of QT prolongation: a pharmacovigilance study","volume":"240","author":"Bordet","year":"2023","journal-title":"Psychopharmacol (Berl)"},{"issue":"1","key":"10.1016\/j.xjmad.2026.100195_bib34","article-title":"A Review of Olanzapine in the Treatment of Cancer Anorexia-Cachexia Syndrome","volume":"12","author":"Poon","year":"2024","journal-title":"Pharm (Basel)"},{"key":"10.1016\/j.xjmad.2026.100195_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.613625","article-title":"QT Prolongation in Cancer Patients","volume":"8","author":"Kim","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"2","key":"10.1016\/j.xjmad.2026.100195_bib36","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00702-023-02589-7","article-title":"Antipsychotic drug-induced neutropenia: results from the AMSP drug surveillance program between 1993 and 2016","volume":"130","author":"Glocker","year":"2023","journal-title":"J Neural Transm (Vienna)"},{"issue":"1","key":"10.1016\/j.xjmad.2026.100195_bib37","doi-asserted-by":"crossref","DOI":"10.1017\/S1092852925100576","article-title":"Clozapine and anti-cancer agents: a systematic literature review of case reports","volume":"30","author":"Honor","year":"2025","journal-title":"CNS Spectr"},{"issue":"9","key":"10.1016\/j.xjmad.2026.100195_bib38","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s00702-024-02818-7","article-title":"Clozapine-associated adverse drug reactions in 38,349 psychiatric inpatients: drug surveillance data from the AMSP project between 1993 and 2016","volume":"131","author":"Bleich","year":"2024","journal-title":"J Neural Transm (Vienna)"},{"issue":"ement","key":"10.1016\/j.xjmad.2026.100195_bib39","article-title":"Management of brain tumor-related epilepsy","volume":"65","author":"Klinger","year":"2017","journal-title":"Neurol India"},{"issue":"7","key":"10.1016\/j.xjmad.2026.100195_bib40","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1358\/mf.2004.26.7.863736","article-title":"Therapeutic drug monitoring of non-anticancer drugs in cancer patients","volume":"26","author":"Joerger","year":"2004","journal-title":"Methods Find Exp Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.xjmad.2026.100195_bib41","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/hup.2362","article-title":"Novel markers of kidney injury in bipolar patients on long-term lithium treatment","volume":"28","author":"Rybakowski","year":"2013","journal-title":"Hum Psychopharmacol"},{"issue":"12","key":"10.1016\/j.xjmad.2026.100195_bib42","first-page":"4151","article-title":"Management of nephrotoxicity of chemotherapy and targeted agents: 2020","volume":"10","author":"Chiruvella","year":"2020","journal-title":"Am J Cancer Res"},{"issue":"4","key":"10.1016\/j.xjmad.2026.100195_bib43","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2016-000091","article-title":"Renal insufficiency and cancer treatments","volume":"1","author":"Launay-Vacher","year":"2016","journal-title":"ESMO Open"},{"issue":"9817","key":"10.1016\/j.xjmad.2026.100195_bib44","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0140-6736(11)61516-X","article-title":"Lithium toxicity profile: a systematic review and meta-analysis","volume":"379","author":"McKnight","year":"2012","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.xjmad.2026.100195_bib45","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1634\/theoncologist.2013-0237","article-title":"Hypothyroidism after a cancer diagnosis: etiology, diagnosis, complications, and management","volume":"19","author":"Carter","year":"2014","journal-title":"Oncologist"},{"issue":"2-3","key":"10.1016\/j.xjmad.2026.100195_bib46","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.tox.2005.10.004","article-title":"Valproic acid monotherapy induces DNA oxidative damage","volume":"217","author":"Schulpis","year":"2006","journal-title":"Toxicology"},{"key":"10.1016\/j.xjmad.2026.100195_bib47","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/815105","article-title":"Liver injury induced by anticancer chemotherapy and radiation therapy","volume":"2013","author":"Maor","year":"2013","journal-title":"Int J Hepatol"},{"key":"10.1016\/j.xjmad.2026.100195_bib48","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.seizure.2021.11.018","article-title":"Predicting the occurrence of thrombocytopenia from free valproate levels: A prospective study","volume":"94","author":"Nasreddine","year":"2022","journal-title":"Seizure"},{"issue":"3","key":"10.1016\/j.xjmad.2026.100195_bib49","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1528-1167.2007.00924.x","article-title":"A comparative pharmacokinetic study in healthy volunteers of the effect of carbamazepine and oxcarbazepine on cyp3a4","volume":"48","author":"Andreasen","year":"2007","journal-title":"Epilepsia"},{"issue":"8","key":"10.1016\/j.xjmad.2026.100195_bib50","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.clinthera.2008.08.011","article-title":"Drug interactions between chemotherapeutic regimens and antiepileptics","volume":"30","author":"Yap","year":"2008","journal-title":"Clin Ther"},{"issue":"7","key":"10.1016\/j.xjmad.2026.100195_bib51","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/epi.13777","article-title":"Carbamazepine- and oxcarbazepine-induced hyponatremia in people with epilepsy","volume":"58","author":"Berghuis","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.xjmad.2026.100195_bib52","doi-asserted-by":"crossref","DOI":"10.1177\/1758835919877725","article-title":"Syndrome of inappropriate anti-diuretic hormone secretion in cancer patients: results of the first multicenter Italian study","volume":"11","author":"Berardi","year":"2019","journal-title":"Ther Adv Med Oncol"},{"issue":"7","key":"10.1016\/j.xjmad.2026.100195_bib53","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s10072-014-1701-0","article-title":"Anticonvulsant drugs and hematological disease","volume":"35","author":"Verrotti","year":"2014","journal-title":"Neurol Sci"},{"issue":"2","key":"10.1016\/j.xjmad.2026.100195_bib54","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/bjh.20221","article-title":"Lamotrigine and anti-seizure medications in HLH: A systematic review","volume":"207","author":"Gummadi","year":"2025","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.xjmad.2026.100195_bib55","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.jid.2017.01.031","article-title":"The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in the UK","volume":"137","author":"Frey","year":"2017","journal-title":"J Invest Dermatol"},{"issue":"18","key":"10.1016\/j.xjmad.2026.100195_bib56","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1200\/JCO.23.00293","article-title":"Management of Anxiety and Depression in Adult Survivors of Cancer: ASCO Guideline Update","volume":"41","author":"Andersen","year":"2023","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.xjmad.2026.100195_bib57","doi-asserted-by":"crossref","first-page":"e362","DOI":"10.1016\/j.clbc.2021.10.003","article-title":"Time to Update Evidence-Based Guideline Recommendations About Concurrent Tamoxifen and Antidepressant Use? A Systematic Review","volume":"22","author":"Bradbury","year":"2022","journal-title":"Clin Breast Cancer"},{"issue":"2","key":"10.1016\/j.xjmad.2026.100195_bib58","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.clbc.2017.12.012","article-title":"Effect of Aromatase Inhibitor Therapy on Sleep and Activity Patterns in Early-stage Breast Cancer","volume":"18","author":"Bhave","year":"2018","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.xjmad.2026.100195_bib59","series-title":"AROMASIN\u00ae (exemestane) tablets, for oral use: prescribing information","article-title":"Editor","author":"LLC","year":"2024"},{"issue":"5","key":"10.1016\/j.xjmad.2026.100195_bib60","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.psym.2020.06.003","article-title":"End-of-Life Care in Individuals With Serious Mental Illness","volume":"61","author":"Shalev","year":"2020","journal-title":"Psychosomatics"},{"key":"10.1016\/j.xjmad.2026.100195_bib61","series-title":"End-of-life care for people with severe mental illness: the MENLOC evidence synthesis","article-title":"Health and Social Care Delivery Research","author":"Hannigan","year":"2022"},{"issue":"2","key":"10.1016\/j.xjmad.2026.100195_bib62","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1001\/jamapsychiatry.2020.2993","article-title":"Adjunctive Psychotherapy for Bipolar Disorder: A Systematic Review and Component Network Meta-analysis","volume":"78","author":"Miklowitz","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"10.1016\/j.xjmad.2026.100195_bib63","article-title":"Review of Psychological Interventions in Oncology: Current Trends and Future Directions","volume":"61","author":"Anghel","year":"2025","journal-title":"Med (Kaunas)"},{"key":"10.1016\/j.xjmad.2026.100195_bib64","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cpr.2018.12.001","article-title":"Fear of cancer recurrence: A qualitative systematic review and meta-synthesis of patients' experiences","volume":"68","author":"Almeida","year":"2019","journal-title":"Clin Psychol Rev"},{"issue":"4","key":"10.1016\/j.xjmad.2026.100195_bib65","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s11764-022-01277-x","article-title":"Therapeutic intervention in fear of cancer recurrence in adult oncology patients: a systematic review","volume":"17","author":"Paper\u00e1k","year":"2023","journal-title":"J Cancer Surviv"},{"issue":"1","key":"10.1016\/j.xjmad.2026.100195_bib66","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1037\/a0024946","article-title":"A test of the bidirectional association between sleep and mood in bipolar disorder and insomnia","volume":"121","author":"Talbot","year":"2012","journal-title":"J Abnorm Psychol"},{"issue":"11","key":"10.1016\/j.xjmad.2026.100195_bib67","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/pcn.13729","article-title":"Sleep and circadian disruption in bipolar disorders: From psychopathology to digital phenotyping in clinical practice","volume":"78","author":"Tonon","year":"2024","journal-title":"Psychiatry Clin Neurosci"},{"issue":"1","key":"10.1016\/j.xjmad.2026.100195_bib68","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3390\/clockssleep1010014","article-title":"Sleep in Hospitalized Patients","volume":"1","author":"Morse","year":"2019","journal-title":"Clocks Sleep"}],"container-title":["Journal of Mood &amp; Anxiety Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950004426000301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950004426000301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:24:26Z","timestamp":1790209466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950004426000301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":68,"alternative-id":["S2950004426000301"],"URL":"https:\/\/doi.org\/10.1016\/j.xjmad.2026.100195","relation":{},"ISSN":["2950-0044"],"issn-type":[{"value":"2950-0044","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bipolar disorder in oncology: Considerations for the psychiatrist","name":"articletitle","label":"Article Title"},{"value":"Journal of Mood & Anxiety Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xjmad.2026.100195","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of Anxiety and Depression Association of America.","name":"copyright","label":"Copyright"}],"article-number":"100195"}}